No Data
No Data
If EPS Growth Is Important To You, United Therapeutics (NASDAQ:UTHR) Presents An Opportunity
United Therapeutics(UTHR.US) Officer Sells US$3.65 Million in Common Stock
United Therapeutics Analyst Ratings
UBS Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $475
United Therapeutics(UTHR.US) Officer Sells US$3.55 Million in Common Stock
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
長崎 そよ : A stock that doesn't move at all.